ClassID:

21465

A61K49/0447 - CPC Classification

Classification description:

Preparations for testing; X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound

Sub-classes:
Recent Application in this class:
#1
20220096664
2022-03-31

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

#2
20200353103
2020-11-12

Contrast imaging agent with dissolved gas-evolving fluid

#3
20200197541
2020-06-25

GEL FORMULATIONS FOR GUIDING RADIOTHERAPY

#4
20200054770
2020-02-20

RADIOPAQUE POLYMERS WITH ENHANCED RADIOPACITY

#5
20190046666
2019-02-14

Radio-opaque writing instruments and methods of use

#6
20180085184
2018-03-29

Imaging fiducial markers and methods

#7
20180064830
2018-03-08

CONTRAST IMAGING AGENT WITH DISSOLVED GAS-EVOLVING FLUID

#8
20160304440
2016-10-20

Purification of X-ray contrast agents

#9
20160100910
2016-04-14

Imaging fiducial markers and methods

#10
20150173848
2015-06-25

Imaging fiducial markers and methods

#11
20140187911
2014-07-03

Tissue marker for multimodality radiographic imaging

#12
20130130295
2013-05-23

Carbon nanotube based imaging agents

#13
20130072792
2013-03-21

ULTRASONICALLY VISIBLE BALLOON CATHETER ASSEMBLY AND METHOD OF IMAGING A MEDICAL BALLOON

#14
20120184545
2012-07-19

HEART-SLOWING DRUG CONTAINING SHORT-ACTING BETA-BLOCKER AS TEH ACTIVE INGREDIENT

#15
20120076734
2012-03-29

RADIOPAQUE ANTIBIOTIC DENTAL PASTE AND USES THEREOF

#16
20100287887
2010-11-18

Tissue marker for multimodality radiographic imaging

#17
20100284919
2010-11-11

Injectable Radio-Opaque Compositions for Tissue Augmentation

#18
20100278997
2010-11-04

Preparation for restenosis prevention

#19
20100278744
2010-11-04

Preparation for restenosis prevention

#20
20100266501
2010-10-21

METHODS AND COMPOSITIONS FOR ORGAN PROTECTION

#21
20100003190
2010-01-07

Method for protecting renal tubular epithelial cells from radiocontrast nephropathy (RCN)

#22
20090240142
2009-09-24

Systems and method of delivering fluids to a patient of varying concentration

#23
20090136987
2009-05-28

Carbon Nanotube Based Imaging Agents

#24
20080206134
2008-08-28

Radio-opaque hemostatic agents and devices and methods for the delivery thereof

#25
20080199403
2008-08-21

Composition and Method for Direct Visualization of the Human Appendix

#26
20080107709
2008-05-08

RADIO-OPAQUE POLYMERIC BIOMATERIALS

#27
20080102034
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

#28
20080102033
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

#29
20070280406
2007-12-06

ORIENTATION IDENTIFICATION

#30
20070269406
2007-11-22

Transcatheter tumor immunoembolization

#31
20070128120
2007-06-07

Organic radiographic contrasting agents for medical devices

#32
20070123478
2007-05-31

COMPOSITIONS USEFUL FOR REDUCING NEPHROTOXICITY AND METHODS OF USE THEREOF

#33
20070110665
2007-05-17

Tissue marker for multimodality radiographic imaging

#34
20060286037
2006-12-21

Heart-slowing drug containing short-acting ß blocker as the active ingredient

#35
20060251577
2006-11-09

Composition and method for direct visualization of the human appendix

#36
20060204440
2006-09-14

Radio-opaque polymeric biomaterials

#37
20050255045
2005-11-17

Surgical marking composition and method

#38
20050250672
2005-11-10

Preparation for the prophylaxis of restenosis

#39
20050180920
2005-08-18

Oral contrast media composition for computerized axial tomographic examinations and method

#40
20050123481
2005-06-09

Radio-opaque polymeric biomaterials

#41
20050101522
2005-05-12

Preparation for the prophylaxis of restenosis

#42
20050063904
2005-03-24

Method for continuous visualization of a blood clot or plaque in body lumen

#43
16928863
2022-06-28

Radio-opaque writing instruments and methods of use